Los G, Mutsaers P H, van der Vijgh W J, Baldew G S, de Graaf P W, McVie J G
The Netherlands Cancer Institute, Division of Experimental Chemotherapy, Amsterdam.
Cancer Res. 1989 Jun 15;49(12):3380-4.
Chemotherapy i.p. is increasingly being tested as a treatment modality for cancer limited to the peritoneal cavity. We have developed a rat tumor model in which penetration and distribution of cis-diamminedichloroplatinum(II) into intraperitoneal tumors have been studied. The platinum concentration in intraperitoneal tumor nodules, measured by two techniques, flameless atomic absorption spectroscopy and proton-induced X-ray emission, was always higher after i.p. treatment than i.v. Further, platinum concentrations were higher at the periphery of the tumor after i.p. administration than after i.v., while platinum concentrations in the center of the tumor nodules were identical. No difference was detected in platinum concentrations in s.c. tumors nor in the total area under the curve (plasma) after i.p. and i.v. administration of cis-diamminedichloroplatinum(II), suggesting that the higher drug concentration measured in peritoneal tumors after i.p. administration is due to direct diffusion of the drug from the peritoneal cavity.
腹腔内化疗作为一种针对局限于腹膜腔的癌症的治疗方式,正越来越多地接受测试。我们建立了一种大鼠肿瘤模型,在该模型中研究了顺二氯二氨铂(II)在腹腔内肿瘤中的渗透和分布情况。通过无火焰原子吸收光谱法和质子诱导X射线发射这两种技术测量,腹腔内给药后腹腔内肿瘤结节中的铂浓度始终高于静脉内给药。此外,腹腔内给药后肿瘤周边的铂浓度高于静脉内给药,而肿瘤结节中心的铂浓度相同。腹腔内和静脉内给予顺二氯二氨铂(II)后,皮下肿瘤中的铂浓度以及曲线下总面积(血浆)均未检测到差异,这表明腹腔内给药后在腹膜肿瘤中测得的较高药物浓度是由于药物从腹膜腔直接扩散所致。